SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The Amateur Traders Corner

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom Hua who wrote (16579)11/29/2001 7:05:11 AM
From: JustTradeEm  Read Replies (2) of 19633
 
Good Morning Tom, regarding ACAM / BREL ...

In reading the press release, apparently the second ACAM contract is at roughly $2.76 per dose whereas the original contract was roughly $6.34 per dose.

I've still not been able to divine the involvement of BREL ( if any ) in the second contract since it is being co-manufactured by ACAM and Baxter. No mention of BREL in ACAM's release.

Any thoughts ?

JB .... who is watching BREL, NVDA, BRCD and FMKT today for entries.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext